Skip to main content
NVDA-0.19%AAPL+1.11%GOOGL-2.28%MSFT+0.03%AMZN-0.01%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.84%TSLA-0.42%SKHY+7.05%MU-1.35%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.54%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.65%0005.HK-0.78%HSBA.L-1.45%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.22%CHFJPY-1.73%USDJPY-1.64%AUDJPY-1.55%EURJPY-1.46%CADJPY-1.44%GBPJPY-1.39%GBPNZD+0.83%NZDCAD-0.80%EURNZD+0.79%AUDNZD+0.70%NZDUSD-0.60%NZDCHF-0.52%GBPTRY+0.41%GBPCHF+0.33%GBPHKD+0.32%GBPMXN-0.28%CADCHF+0.28%EURCHF+0.27%GBPUSD+0.25%GBPZAR+0.22%EURZAR+0.22%EURNOK+0.21%USDZAR+0.21%USDNOK+0.20%NZDSGD+0.19%USDCAD-0.19%AUDCHF+0.19%EURUSD+0.18%NZDMXN+0.17%USDILS+0.16%CHFNOK+0.16%AUDCAD-0.14%GBPAUD+0.14%AUDDKK-0.12%USDTHB+0.12%NOKJPY-0.11%USDTRY+0.11%USDCHF+0.10%EURCZK-0.09%EURAUD+0.09%AUDNOK+0.09%AUDUSD+0.09%EURSEK+0.08%GBPSGD+0.07%EURSGD+0.07%EURPLN+0.07%USDSEK+0.07%USDSGD+0.06%USDPLN+0.06%USDMXN+0.06%AUDSGD-0.05%EURGBP-0.05%USDCOP-0.04%PLNJPY+0.03%USDCNH-0.03%SGDJPY+0.03%GBPCAD+0.03%CHFSEK+0.02%EURCAD-0.02%CHFSGD+0.02%USDHKD+0.01%USDDKK-0.01%EURDKK0.00%EURCNH0.00%EURHKD0.00%COFFEE-2.46%SUGAR+1.85%XPTUSD-1.72%COTTON+1.40%COCOA-1.30%GAGUSD-1.06%XAGUSD-1.04%HG1-0.97%USOIL+0.67%S1+0.53%C1+0.47%UKOIL+0.47%BTCUSD-0.43%ETHUSD0.00%USDTUSD-0.03%XRPUSD-1.28%SOLUSD-0.49%TRXUSDT+0.42%ZECUSDT-1.76%DOGEUSD-1.44%XMRUSDT-0.83%LINKUSD-0.08%XLMUSD-1.08%BCHUSDT-1.93%LTCUSD-1.59%UNIUSD-2.13%TONUSD+24.88%HBARUSDT-1.31%SUIUSD-1.38%TAOUSDT-1.11%AAVEUSD-1.67%DOTUSDT-2.18%ICPUSDT-1.08%ONDOUSDT-2.09%WLDUSDT-1.95%ATOMUSDT-2.11%ARBUSDT-0.27%JUPUSDT-2.96%INJUSDT-2.70%STXUSDT-2.70%FETUSDT-2.39%TIAUSDT-0.87%SEIUSDT-3.91%PYTHUSDT-1.24%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.33%OPUSDT-1.99%POLUSDT-3.22%IOTAUSDT-2.53%AXSUSDT-2.04%FARTCOINUSDT-1.57%EOSUSDT+0.06%DYDXUSDT-0.80%ORDIUSDT+0.59%GALAUSDT-3.09%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.19%AAPL+1.11%GOOGL-2.28%MSFT+0.03%AMZN-0.01%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.84%TSLA-0.42%SKHY+7.05%MU-1.35%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.54%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.65%0005.HK-0.78%HSBA.L-1.45%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.22%CHFJPY-1.73%USDJPY-1.64%AUDJPY-1.55%EURJPY-1.46%CADJPY-1.44%GBPJPY-1.39%GBPNZD+0.83%NZDCAD-0.80%EURNZD+0.79%AUDNZD+0.70%NZDUSD-0.60%NZDCHF-0.52%GBPTRY+0.41%GBPCHF+0.33%GBPHKD+0.32%GBPMXN-0.28%CADCHF+0.28%EURCHF+0.27%GBPUSD+0.25%GBPZAR+0.22%EURZAR+0.22%EURNOK+0.21%USDZAR+0.21%USDNOK+0.20%NZDSGD+0.19%USDCAD-0.19%AUDCHF+0.19%EURUSD+0.18%NZDMXN+0.17%USDILS+0.16%CHFNOK+0.16%AUDCAD-0.14%GBPAUD+0.14%AUDDKK-0.12%USDTHB+0.12%NOKJPY-0.11%USDTRY+0.11%USDCHF+0.10%EURCZK-0.09%EURAUD+0.09%AUDNOK+0.09%AUDUSD+0.09%EURSEK+0.08%GBPSGD+0.07%EURSGD+0.07%EURPLN+0.07%USDSEK+0.07%USDSGD+0.06%USDPLN+0.06%USDMXN+0.06%AUDSGD-0.05%EURGBP-0.05%USDCOP-0.04%PLNJPY+0.03%USDCNH-0.03%SGDJPY+0.03%GBPCAD+0.03%CHFSEK+0.02%EURCAD-0.02%CHFSGD+0.02%USDHKD+0.01%USDDKK-0.01%EURDKK0.00%EURCNH0.00%EURHKD0.00%COFFEE-2.46%SUGAR+1.85%XPTUSD-1.72%COTTON+1.40%COCOA-1.30%GAGUSD-1.06%XAGUSD-1.04%HG1-0.97%USOIL+0.67%S1+0.53%C1+0.47%UKOIL+0.47%BTCUSD-0.43%ETHUSD0.00%USDTUSD-0.03%XRPUSD-1.28%SOLUSD-0.49%TRXUSDT+0.42%ZECUSDT-1.76%DOGEUSD-1.44%XMRUSDT-0.83%LINKUSD-0.08%XLMUSD-1.08%BCHUSDT-1.93%LTCUSD-1.59%UNIUSD-2.13%TONUSD+24.88%HBARUSDT-1.31%SUIUSD-1.38%TAOUSDT-1.11%AAVEUSD-1.67%DOTUSDT-2.18%ICPUSDT-1.08%ONDOUSDT-2.09%WLDUSDT-1.95%ATOMUSDT-2.11%ARBUSDT-0.27%JUPUSDT-2.96%INJUSDT-2.70%STXUSDT-2.70%FETUSDT-2.39%TIAUSDT-0.87%SEIUSDT-3.91%PYTHUSDT-1.24%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-2.33%OPUSDT-1.99%POLUSDT-3.22%IOTAUSDT-2.53%AXSUSDT-2.04%FARTCOINUSDT-1.57%EOSUSDT+0.06%DYDXUSDT-0.80%ORDIUSDT+0.59%GALAUSDT-3.09%NOTUSDT-0.68%RONINUSDT-0.71%
PB

Pulse Biosciences, Inc. (PLSE)

NASDAQ • Healthcare

$52.97
+$4.18 (+8.6%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$49.76
Day Range$48.43 - $58.9
Avg. Volume (3M)563.9K
Market Cap$3.6B
52 Week Range
$12.56$58.9
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$434K100%
Gross Profitminus cost of goods$161K37%

Fundamentals & Financials

Revenue (TTM)
$1.1M
Net Income (TTM)
-$80M
EPS (TTM)
-$1.17
ROA (TTM)
-69.27%
Current Ratio
9.63

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+1.9%Q1 2026-$0.26
+15.6%Q2 2026-$0.27
-16.1%Q3 2026-$0.36
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -16.1%

Pulse Biosciences trailed consensus on both EPS and revenue in the second fiscal quarter of 2026, reported August 6, 2026, with EPS of -$0.36 trailing the -$0.31 estimate by -$0.05 and revenue of $434,000.00 trailing the $500,000.00 estimate (-13.2%). Net income came in at roughly -$24.7 million, down 29% from about -$19.2 million a year ago, and EPS was down 29% from -$0.28 a year ago. The quarter also posted an operating loss of about -$25.3 million, alongside revenue of about $0.4 million. For the next period, consensus calls for EPS of -$0.35 on revenue of $625,000.00.

View full earnings history

About Pulse Biosciences, Inc.

Pulse Biosciences, Inc. develops medical technology and trades on the NASDAQ under PLSE. In healthcare, it operates as a maker of medical instruments and supplies built around the CellFX System, and it fits the profile of a small-cap device company founded in 2014.

Name
Pulse Biosciences, Inc.
CEO
Paul Arthur LaViolette
Website
www.pulsebiosciences.com
Industry
Healthcare
Year Founded
2014
Employees
116

Today's Snapshot

AI-generated

The day ended with PLSE 8.6% higher at 52.97, while its sector was flat. Shares changed hands at roughly twice its usual level.

Trading Volume

Above 10d avg 711.8K

1.5M

vs S&P 500 Today

Strong Outperformance

+8.99%

Updated: September 9, 2026 at 20:21 UTC

Technical Indicators

5 Buy3 Neutral0 Sell
PLSE, at about 53, shows clear technical strength: a very high ADX indicates a dominant trend while momentum gauges—RSI in the mid-60s and a bullish CCI—point to sustained upside momentum. Price is trading well above its short-, medium- and long-term moving averages, including a 200-day average well below current levels, which signals broad-based strength, and on-balance volume is supportive. Volatility is moderate and the classic pivot sits beneath the market. Technical takeaway: strong trend, momentum and volume alignment justify the strong-buy stance.
All signals
  • EMA (5 indicators)$27.36 - $50.94
    Buy
  • RSI (14)64.58
    Neutral
  • Stochastic %K (14, 3, 3)53.20
    Neutral
  • MACD Level (12, 26)3.83
    Neutral

Peers & Related Assets

DNTHDianthus Therapeutics, Inc.
$107.04-1.9%
NVCRNovocure Ltd
$15.63-7.2%
KMTSKestra Medical Technologies, Ltd.
$24.07-6.1%
STAASTAAR Surgical Company
$23.62-2.2%
OPKOPKO Health, Inc.
$1.54-3.1%
BBNXBeta Bionics, Inc.
$17.42-9.9%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.